We demonstrate that IL-33 catered by Cxcl13-Cre+ FSCs to tumor-infiltrating CD8+ T cells reduces local T cell exhaustion and thereby sustains control of tumor growth. The gene discussed is CXCL13; the disease is neoplasm.